Ono Pharma Enters into a Development and License Agreement with Numab

Ono Pharmaceutical Co., Ltd., announced that it has exercised its option to enter into a development and license agreement with Numab Therapeutics AG (Waedenswil, Switzerland; CEO, David Urech;